doi: 10.1001/jama.2021.3854.
Evaluation of Aducanumab for Alzheimer Disease: Scientific Evidence and Regulatory Review Involving Efficacy, Safety, and Futility
Affiliations
- PMID: 33783469
- DOI: 10.1001/jama.2021.3854
Item in Clipboard
Evaluation of Aducanumab for Alzheimer Disease: Scientific Evidence and Regulatory Review Involving Efficacy, Safety, and Futility
JAMA.
.
No abstract available
Similar articles
-
Controversial Approval of New Drug to Treat Alzheimer's Disease.Am J Nurs. 2021 Oct 1;121(10):22-23. doi: 10.1097/01.NAJ.0000794244.40800.99. Am J Nurs. 2021. PMID: 34554982
-
What the Aducanumab Approval Reveals About Alzheimer Disease Research.JAMA Neurol. 2021 Nov 1;78(11):1305-1306. doi: 10.1001/jamaneurol.2021.3404. JAMA Neurol. 2021. PMID: 34605885 No abstract available.
-
The Problem of Aducanumab for the Treatment of Alzheimer Disease.Ann Intern Med. 2021 Sep;174(9):1303-1304. doi: 10.7326/M21-2603. Epub 2021 Jun 17. Ann Intern Med. 2021. PMID: 34138642 No abstract available.
-
Can we learn lessons from the FDA's approval of aducanumab?Nat Rev Neurol. 2021 Nov;17(11):715-722. doi: 10.1038/s41582-021-00557-x. Epub 2021 Sep 17. Nat Rev Neurol. 2021. PMID: 34535787 Review.
-
Aducanumab and the FDA - where are we now?Nat Rev Neurol. 2021 Mar;17(3):129-130. doi: 10.1038/s41582-020-00454-9. Nat Rev Neurol. 2021. PMID: 33442064 Review. No abstract available.
Cited by
-
Pharmacogenomics of Dementia: Personalizing the Treatment of Cognitive and Neuropsychiatric Symptoms.Genes (Basel). 2023 Nov 6;14(11):2048. doi: 10.3390/genes14112048. Genes (Basel). 2023. PMID: 38002991 Free PMC article. Review.
-
Limitations and potential strategies of immune checkpoint blockade in age-related neurodegenerative disorders.J Physiol Sci. 2024 Sep 23;74(1):46. doi: 10.1186/s12576-024-00933-4. J Physiol Sci. 2024. PMID: 39313800 Free PMC article. Review.
-
Aducanumab, a Novel Anti-Amyloid Monoclonal Antibody, for the Treatment of Alzheimer's Disease: A Comprehensive Review.Health Psychol Res. 2022 Jan 30;10(1):31925. doi: 10.52965/001c.31925. eCollection 2022. Health Psychol Res. 2022. PMID: 35928986 Free PMC article.
-
Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer's disease, frontotemporal dementia and progressive supranuclear palsy.J Neurol Neurosurg Psychiatry. 2022 Jun;93(6):651-658. doi: 10.1136/jnnp-2021-327788. Epub 2022 Jan 25. J Neurol Neurosurg Psychiatry. 2022. PMID: 35078917 Free PMC article.
-
Lipid metabolism transcriptomics of murine microglia in Alzheimer's disease and neuroinflammation.Sci Rep. 2023 Sep 8;13(1):14800. doi: 10.1038/s41598-023-41897-6. Sci Rep. 2023. PMID: 37684405 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
